Fulcrum Therapeutics (FULC) Enterprise Value (QoQ) (2018 - 2026)
Fulcrum Therapeutics (FULC) Enterprise Value (QoQ) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
| 10 |
Fulcrum Therapeutics |
267.90 Mn |
267.90 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-68.74% |
| Dec 31, 2025 |
-319.59% |
| Sep 30, 2025 |
78.01% |
| Jun 30, 2025 |
-407.64% |
| Mar 31, 2025 |
82.50% |
| Dec 31, 2024 |
-231.85% |
| Sep 30, 2024 |
16.23% |
| Jun 30, 2024 |
-117.03% |
| Mar 31, 2024 |
83.09% |
| Dec 31, 2023 |
-685.31% |
| Sep 30, 2023 |
11.44% |
| Jun 30, 2023 |
2.21% |
| Mar 31, 2023 |
1.04% |
| Dec 31, 2022 |
61.40% |
| Sep 30, 2022 |
-126.48% |
| Jun 30, 2022 |
-20.53% |
| Mar 31, 2022 |
5.93% |
| Dec 31, 2021 |
45.91% |
| Sep 30, 2021 |
-15.31% |
| Jun 30, 2021 |
43.64% |
